KFS
GSK icon

Kurt F. Somerville’s GSK GSK Stock Holding History

Kurt F. Somerville’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,800
Closed -$227K – 115
2020
Q1 		$227K Buy
+4,800
New +$256K 0.05% 96
2015
Q2 		– Sell
-3,484
Closed -$201K – 138
2015
Q1 		$201K Sell
3,484
-4,488
-56% -$257K 0.05% 124
2014
Q4 		$426K Sell
7,972
-18,168
-70% -$1.02M 0.11% 92
2014
Q3 		$1.5M Sell
26,140
-6,788
-21% -$416K 0.61% 43
2014
Q2 		$2.2M Buy
32,928
+6,852
+26% +$464K 0.86% 39
2014
Q1 		$1.74M Buy
26,076
+5,404
+26% +$365K 0.69% 42
2013
Q4 		$1.38M Buy
20,672
+6,908
+50% +$448K 0.53% 44
2013
Q3 		$864K Buy
13,764
+5,944
+76% +$383K 0.34% 58
2013
Q2 		$488K Buy
+7,820
New +$496K 0.21% 73

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kurt F. Somerville's GSK Position: Q2 2020 in Review

Kurt F. Somerville sold out of GSK (GSK) in Q2 2020, closing a stake of 4,800 shares — an estimated $227K sold.

Kurt F. Somerville first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $2.2M in Q2 2014. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Kurt F. Somerville reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Kurt F. Somerville sold 4,800 GSK shares in Q2 2020, an estimated $227K.
  • Kurt F. Somerville first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Kurt F. Somerville's GSK position peaked at $2.2M in Q2 2014.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Kurt F. Somerville's 13F filing for Q2 2020, filed 28 Jul 2020.